Abstract
Cell-cell and cell-extracellular matrix (ECM) interactions play fundamental roles in many biological processes. Cells adhere to the ECM and to each other via specific cell surface receptors such as the selectins, integrins, Cadherins, members of the immunoglobulin superfamily, and of the CD44 superfamily [1]. Surface molecules are necessary for cellular cross-talking and thus have a major impact on gene regulation, immune surveillance, immunological memory, motility, differentiation and growth control. Defined alterations in the cellular communication are features of embryonic development, immunobiology and neoplastic transformation. The model molecule and its functional analysis described here is the glycoprotein CD44 and its many isoforms [2]. CD44 has been implicated to act in processes such as lymphocyte homing, haematopoiesis, tumour dissemination, lymphocyte activation, pattern formation in embryogenesis and inflammatory reactions [2–5]. This multipurpose nature of CD44 can possibly be explained by the enormous number of isoforms. Although only encoded by one gene, CD44 represents a large family of molecules which differ in the primary structure. These differences are brought about by alternative splicing of at least ten unique exons, encoding extracellular regions. The function of the variant isoforms has been a matter of speculation for a long time, but now analysing mice which carry targeted mutations of specific exons a clearer picture is emerging.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ruiz, P., Günthert, U., 1996: The cellular basis of metastasis. World J. Urol. 14, 141–150.
Günthert, U., 1996: CD44 in malignant disorders. Current Topics Microbiol. Immunol. 213-I: 271–285. Editors U. Günthert, W. Birchmeier and P.M. Schlag of Vol. 213 I, II, III: Attempts to understand metastasis formation. Springer, Heidelberg.
Stauder, R., Günthert, U., 1995: CD44 isoforms-impact on lymphocyte activation and differentiation. The Immunologist 3, 78–83.
Ruiz, P., Schwärzler, C., Günthert, U., 1995: CD44 isoforms during differentiation and development. BioEssays 17, 17–24.
Günthert, U., Stauder, R., Mayer, B., Terpe, H.-J., Finke, L., Friedrichs, K., 1995: Are CD44 variant isoforms involved in human tumour progression? Cancer Surveys 24, 19–42.
Rosenberg, W.M.C., Prince, C., Kaklamanis, L., Fox, S.B., Jackson, D.G., Simmons, D.L., Chapman, R.W., Trowell, J.M., Jewell, D.P., Bell, J.I., 1995: Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn’s disease. Lancet 345, 1205–1209.
Neurath, M.F., Fuss, I., Kelsall, B.L., Stüber, E.R., Strober, W., 1995: Antibodies to IL-12 abrogate established experimental colitis in mice. J. Exp. Med. 182, 1281–1290.
Wittig, B., Seiter, S., Föger, N., Schwärzler, C., Günthert, U., Zöller, M., 1997: Functional activity of murine CD44 variant isoforms in allergic and delayed type hypersensitivity. Immunol. Lett. 57: 217–223.
Powrie, F., 1995: T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity 3, 171–174.
Gerritse, K., Laman, J.D., Noelle, R.J., Aruffo, A., Ledbetter, J.A., Boersma, W.J.A., Claassen, E., 1996: CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. USA 93, 2499–2504.
Mikecz, K., Brennan, F.R., Kim, J.H., Giant, T.T., 1995: Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis. Nature Med. 1, 558–563.
Dzierzak, E., Medvinsky, A., 1995: Mouse embryonic hematopoiesis. TIG 11, 359–366.
Zuniga-Pflücker, J.C., Lenardo, M., 1996: Regulation of thymocyte development from immature progenitors. Curr. Opin. Immunol. 8, 215–224.
Wu, L., Kincade, P.W., Shortman K., 1993: The CD44 expressed on the earliest intrathymic precursors population functions as a thymus homing molecule but does not bind to hyaluronate. Immunol. Letters 38, 69–75.
Rolink, A., Andersson, J., Ghia, P., Grawunder, U., Haasner, D., Karasuyama, H., ten Boekel, E., Winkler, T.H., Melchers, F., 1995: B-cell development in mouse and men. Immunologist 3/4, 125–128.
Stauder, R., Eisterer, A., Thaler, J., Günthert, U., 1995: CD44 variant isoforms in non-Hodgkin’s lymphoma: A new independent prognostic factor. Blood 85, 2885–2899.
Stauder, R., Van Driel, M., Schwärzler, C., Thaler, J., Lokhorst, H.M., Kreuser, E.D., Bloem, A.C., Günthert, U., Eisterer, W., 1996: Different CD44 splicing patterns define prognostic subgroups in multiple myeloma. Blood 88: 3101–3108.
Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W., Bujard, H., 1995: Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766–1769.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Günthert, U. et al. (1998). Functional Involvement of CD44, a Family of Cell Adhesion Molecules, in Immune Responses, Tumour Progression and Haematopoiesis. In: Walden, P., Trefzer, U., Sterry, W., Farzaneh, F., Zambon, P. (eds) Gene Therapy of Cancer. Advances in Experimental Medicine and Biology, vol 451. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5357-1_7
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5357-1_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7444-2
Online ISBN: 978-1-4615-5357-1
eBook Packages: Springer Book Archive